![Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating Mutations: Evidence for improvement in insulin sensitivity]()
Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating Mutations: Evidence for improvement in insulin sensitivityMalecki, M. T.; Skupien, J.; Klupa, T.; Wanic, K.; Mlynarski, W.; Gach, A.; Solecka, I.; Sieradzki, J. · Diabetes Care · 2007